Literature DB >> 7082466

Septal lesions enhance hyperactivity induced either by amphetamine or lesions of the nucleus accumbens septi.

R J Carey.   

Abstract

Spontaneous locomotor activity was measured in 4 groups of rats subjected to either septal, accumbens, combined septal-accumbens or sham operations. Accumbens but not septal lesions increased activity above control levels and the combined septal-accumbens lesion markedly increased activity levels above that produced by the accumbens lesion. Thus, septal lesions appeared to exaggerate the activity changes produced by the accumbens lesions. Furthermore, both septal and combined septal-accumbens lesions enhanced the hyperactivity induced by 0.25, 0.5 and 1.0 mg/kg D-amphetamine-HCl but attenuated the hyperactivity induced by 0.25, 0.5 and 1.0 mg/kg scopolamine-HCl. Rats with accumbens lesions did not differ from controls in their response to amphetamine or scopolamine. Thus, septal lesions modified both lesion and drug-induced changes in locomotor activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082466     DOI: 10.1016/0166-4328(82)90089-4

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  3 in total

1.  Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.

Authors:  E Kafetzopoulos
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Locomotor activity of rats after injection of various opioids into the nucleus accumbens and the septum mediale.

Authors:  U Havemann; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

3.  Contribution of nucleus accumbens core (AcbC) to behavior control during a learned resting period: introduction of a novel task and lesion experiments.

Authors:  Chika Sato; Masato Hoshino; Naori Ikumi; Kentarou Oba; Akiko Koike; Osamu Shouno; Tatsuhiko Sekiguchi; Tetsuya Kobayashi; Takeo Machida; Gen Matsumoto; Hiroyuki Furudate; Tetsuya Kimura
Journal:  PLoS One       Date:  2014-04-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.